We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+9.88%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$5.45B
AUM Growth
+$379M
Cap. Flow
+$62.7M
Cap. Flow %
1.15%
Top 10 Hldgs %
26.99%
Holding
161
New
18
Increased
65
Reduced
42
Closed
14

Sector Composition

Rank Sector Weight
1 Healthcare 43.08%
2 Technology 23.47%
3 Industrials 13.06%
4 Consumer Discretionary 7.01%
5 Utilities 3.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
LRCX icon
26
Lam Research
LRCX
$372B
$62M 1.14%
1,169,710
+17,940
+2% +$880K
EVH icon
27
Evolent Health
EVH
$358M
$61.7M 1.13%
1,902,755
KRTX
28
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
$61.7M 1.13%
339,898
-179,802
-35% -$34.4M
TTD icon
29
Trade Desk
TTD
$8.59B
$61.2M 1.12%
1,004,358
-460,599
-31% -$24.5M
SGEN
30
DELISTED
Seagen Inc. Common Stock
SGEN
$56.7M 1.04%
279,834
+37,289
+15% +$5.98M
DV icon
31
DoubleVerify
DV
$1.69B
$56.3M 1.03%
1,868,241
-1,350,654
-42% -$35.4M
ZNTL icon
32
Zentalis Pharmaceuticals
ZNTL
$350M
$55.5M 1.02%
3,227,000
+1,070,485
+50% +$21.7M
SPT icon
33
Sprout Social
SPT
$509M
$53.3M 0.98%
875,266
+7,719
+0.9% +$473K
SWAV
34
DELISTED
Shockwave Medical, Inc. Common Stock
SWAV
$52.4M 0.96%
241,875
+202,175
+509% +$39.4M
CLDX icon
35
Celldex Therapeutics
CLDX
$3.02B
$49.6M 0.91%
1,377,740
-85,310
-6% -$3.68M
SHLS icon
36
Shoals Technologies Group
SHLS
$1.49B
$49.6M 0.91%
2,175,089
+654,257
+43% +$16.1M
MIRM icon
37
Mirum Pharmaceuticals
MIRM
$6.87B
$49.5M 0.91%
2,059,201
+2,201
+0.1% +$50.2K
ENTG icon
38
Entegris
ENTG
$17.8B
$49.4M 0.91%
602,683
-104,431
-15% -$8.46M
LSCC icon
39
Lattice Semiconductor
LSCC
$17.7B
$49M 0.9%
512,849
-107,281
-17% -$8.83M
MPWR icon
40
Monolithic Power Systems
MPWR
$64.7B
$48.7M 0.89%
97,331
-20,316
-17% -$9.34M
LNG icon
41
Cheniere Energy
LNG
$54.1B
$47.4M 0.87%
301,076
-95,070
-24% -$14.4M
ASML icon
42
ASML
ASML
$634B
$47.1M 0.86%
69,222
+118
+0.2% +$75.8K
GH icon
43
Guardant Health
GH
$20.2B
$44M 0.81%
1,875,020
+194,020
+12% +$5.54M
XMTR icon
44
Xometry
XMTR
$4.69B
$43.5M 0.8%
2,902,929
+799,697
+38% +$21M
TREX icon
45
Trex
TREX
$4.56B
$42.9M 0.79%
882,234
+234
+0% +$11.8K
CWEN icon
46
Clearway Energy Class C
CWEN
$4.94B
$40.6M 0.75%
1,296,724
+138,609
+12% +$4.45M
HASI icon
47
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.85B
$40.6M 0.75%
1,419,963
+597,299
+73% +$18.9M
COUR icon
48
Coursera
COUR
$1.51B
$39.2M 0.72%
3,403,022
+33,843
+1% +$438K
BEP icon
49
Brookfield Renewable
BEP
$9.9B
$38.9M 0.71%
1,236,000
VRSK icon
50
Verisk Analytics
VRSK
$26.1B
$38.6M 0.71%
201,089
+28,896
+17% +$5.23M

Similar funds

Eventide Asset Management's Q1 2023 Portfolio in Review

As of Q1 2023, Eventide Asset Management held 161 positions worth $5.45B, up 7.5% from $5.07B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Eventide Asset Management's Q1 2023 filing shows 18 new, 65 increased, 42 reduced and 14 closed positions. Its largest new stake was Lithia Motors: 125,499 shares worth $28.7M. The largest sale was ZoomInfo Technologies, an estimated $82.3M.

By sector, the portfolio is most concentrated in Healthcare at 43% of assets, up from 43% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q1 2023 buy was Lithia Motors: 125,499 shares worth $28.7M.
  • Eventide Asset Management added most to Doximity in Q1 2023, an estimated $43.7M increase.
  • Eventide Asset Management's biggest Q1 2023 reduction was ZoomInfo Technologies, cutting an estimated $82.3M.
  • Eventide Asset Management fully exited Bicycle Therapeutics in Q1 2023, selling an estimated $25.3M.
  • Eventide Asset Management's ten largest holdings make up 27% of its $5.45B portfolio in Q1 2023.
  • Eventide Asset Management opened 18 new positions and closed 14 in Q1 2023.
  • Eventide Asset Management's portfolio value rose 7.5% quarter-over-quarter to $5.45B.

Based on Eventide Asset Management's 13F filing for Q1 2023, filed 15 May 2023.